Navigation Links
Olympus Biotech Names Oliver Burckhardt to President North America
Date:5/23/2011

HOPKINTON, Mass., May 23, 2011 /PRNewswire/ -- Olympus Biotech, an Olympus Corporation company, today announced the appointment of Oliver Burckhardt to the position of president of Olympus Biotech Corporation. In his new role, Mr. Burckhardt will lead the company's North American business and focus on expanding opportunities for the emerging regenerative medicine market. Mr. Burckhardt will also become a member of the Olympus Biotech Board of Directors.

"With nearly 20 years in the medical device industry, Oliver's extensive knowledge of the industry and global leadership experience will prove invaluable as we continue to grow Olympus Biotech," said Hitoshi Mizuno, CEO Olympus Biotech Corporation. "We look forward to benefiting from his immense expertise as we continue to lead the creation of this dynamic new field of medicine."

Before joining Olympus Biotech, Mr. Burckhardt most recently served as the international president and CEO of Scient'x Corp in Paris, France, where his strategic vision redefined the company's direction and resulted in double-digit growth. Mr. Burckhardt also served as president of Orthofix, Inc., where he was responsible for the global spine business unit. Prior to that, Mr. Burckhardt spent nine years with Aesculap, Inc. in various sales and marketing positions, including vice president of sales and marketing for the Aesculap Spine division in the United States.

"The Vision of Olympus Biotech to advance into regenerative medicine is the next logical step in the treatment of many medical pathologies and conditions. I am excited about the overall strategic thinking and the assets that are already in place, within Olympus, which represent a perfect starting point for this future oriented strategy," said Mr. Burckhardt. He added, "I look forward to joining the talented team at Olympus Biotech and leveraging my experience in the industry to generate further growth and success."

About Olympus Biotech Corporation

Olympus Biotech was established in December, 2010 as a wholly owned company of Olympus Corporation. The vision of Olympus Biotech is to improve the patient Quality of Life by developing and distributing Regenerative Medicine that stimulate the intrinsic healing capacity in the living body by the technological development of growth factors and biomaterials.

Media Contact:
Jessica Nelson
Kwittken & Company
(646) 747-7141
jnelson@kwitco.com


'/>"/>
SOURCE Olympus Biotech Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Gumz to Retire as President and CEO of Olympus Corporation of the Americas
2. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
3. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
4. Olympus Launches 2011 National Innovation Awards Program
5. Olympus America Licenses Digital Pathology Patents to BioImagene, Inc.
6. Omnyx Licenses Olympus Digital Pathology Patents
7. Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device
8. Generex Biotechnology Corporation CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
9. Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com on May 5th
10. Centocor Ortho Biotech Products, L.P. Voluntarily Withdraws NDA for Trabectedin
11. Immune Design Corp. Appoints Pharma and Biotech Executive Carlos V. Paya, MD, PhD as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral ... Intellectual Property Office has granted Oramed a patent ... Exenatide". The patent covers Oramed,s invention of an ... is an incretin hormone that stimulates the secretion ...
(Date:5/8/2017)... May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., ... ("WRB"), a health care service center company based ... WRB specializes in relationship management programs for leading pharmaceutical ... WRB will join Envoy Health ... services for manufacturers, biotech firms, and other service companies. ...
(Date:5/6/2017)... May 5, 2017  Hill-Rom Holdings, Inc. (NYSE: HRC), ... 100,000 square feet to its Welch Allyn campus. ... commitment to bring more than 100 new jobs to ... Allyn has maintained a significant presence for more than ... new positions, a large portion of which will be ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 26, 2017 , ... Leading CEOs from biotech, pharmaceutical, and ... 31st at The Four Seasons Hotel Boston. , The Boston CEO Conference ... exclusive access to key decision makers who influence deal making and investment. Attendees ...
(Date:5/26/2017)... ... 26, 2017 , ... Somnoware, a leading provider of digital ... its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a sleep device integration ... platform, initializing devices and importing studies are just one-click operations. This plugin streamlines ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... Peace Agreements being discussed by President Donald Trump and the rest of the world. ... speed up peace talks in the continuous battle between Israel and Palestine. The world’s ...
(Date:5/26/2017)... Francisco, CA (PRWEB) , ... May 26, 2017 , ... ... Francisco, is proud to announce a new, informational blog post on insurance options. If ... surgery, checking insurance plans may help save time and money. Visiting an in-network provider ...
Breaking Medicine News(10 mins):